PineBridge Investments’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,237
Closed -$329K 519
2025
Q4
$329K Buy
+3,237
New +$260K ﹤0.01% 500
2023
Q4
Sell
-3,025
Closed -$206K 597
2023
Q3
$206K Buy
3,025
+2,411
+393% +$205K ﹤0.01% 614
2023
Q2
$57.7K Hold
614
﹤0.01% 626
2023
Q1
$41.6K Buy
614
+451
+277% +$29K ﹤0.01% 597
2022
Q4
$8.07K Sell
163
-366
-69% -$15K ﹤0.01% 701
2022
Q3
$17K Sell
529
-123
-19% -$5.07K ﹤0.01% 681
2022
Q2
$26K Sell
652
-232
-26% -$12.4K ﹤0.01% 629
2022
Q1
$62K Buy
+884
New +$64.6K ﹤0.01% 568

Other funds holding EXAS

PineBridge Investments's EXAS Position: Q1 2026 in Review

PineBridge Investments sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 3,237 shares — an estimated $329K sold.

PineBridge Investments first reported a position in EXAS in Q1 2022 and held it in 8 quarters. The position peaked at $329K in Q4 2025. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • PineBridge Investments reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • PineBridge Investments sold 3,237 Exact Sciences shares in Q1 2026, an estimated $329K.
  • PineBridge Investments first reported a position in Exact Sciences in Q1 2022 and held it in 8 quarters.
  • PineBridge Investments's Exact Sciences position peaked at $329K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.